Global Active Pharmaceutical Ingredient Market Status and Outlook 2018-2025

July 2018 | 274 pages | ID: G6AC274341FEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Teva
• Novartis
• Pfizer
• Johnson & Johnson
• Mylan
• North China Pharmaceutical Group
• Dr. Reddy's Laboratories
• Roche
• Aurobindo pharma
• Sun Pharmaceutical Industries
• Boehringer Ingelheim GmbH
• Bayer
• BASF
• DSM
• Zhejiang Medicine
• Biocon
• Johnson Matthey
• Hisun Pharmacy
• Cambrex
• Shandong Xinhua Pharmaceutical
• Lonza group
• Huahai Pharmaceutical
• Haerbin Pharmaceutical Group
• Cipla
• Tian Yao
• Lupin
• North East Pharmaceutical
• Albemarle
• Shandong Lukang Pharmaceutical
• Jiangsu Hengrui Medicine
• Bachem

Market by Type

• Synthetic API
• Biotech API
• Others

Market by Application

• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Oncology Drugs
• Anti-diabetic Drugs
• Cardiovascular Drugs
• Central Nervous System Drugs (CNS Drugs)
• Musculoskeletal Drugs
• Other Drugs

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Active Pharmaceutical Ingredient Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Synthetic API
  3.1.2 Biotech API
  3.1.3 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  4.1.2 Oncology Drugs
  4.1.3 Anti-diabetic Drugs
  4.1.4 Cardiovascular Drugs
  4.1.5 Central Nervous System Drugs (CNS Drugs)
  4.1.6 Musculoskeletal Drugs
  4.1.7 Other Drugs
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Synthetic API Production by Region
    6.1.1.2 Biotech API Production by Region
    6.1.1.3 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Production by Region
    6.1.2.2 Oncology Drugs Production by Region
    6.1.2.3 Anti-diabetic Drugs Production by Region
    6.1.2.4 Cardiovascular Drugs Production by Region
    6.1.2.5 Central Nervous System Drugs (CNS Drugs) Production by Region
    6.1.2.6 Musculoskeletal Drugs Production by Region
    6.1.2.7 Other Drugs Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Synthetic API Demand by Region
    6.2.1.2 Biotech API Demand by Region
    6.2.1.3 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Demand by Region
    6.2.2.2 Oncology Drugs Demand by Region
    6.2.2.3 Anti-diabetic Drugs Demand by Region
    6.2.2.4 Cardiovascular Drugs Demand by Region
    6.2.2.5 Central Nervous System Drugs (CNS Drugs) Demand by Region
    6.2.2.6 Musculoskeletal Drugs Demand by Region
    6.2.2.7 Other Drugs Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Teva
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Novartis
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Pfizer
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Johnson & Johnson
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Mylan
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 North China Pharmaceutical Group
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Dr. Reddy's Laboratories
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Roche
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Aurobindo pharma
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Sun Pharmaceutical Industries
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Boehringer Ingelheim GmbH
8.12 Bayer
8.13 BASF
8.14 DSM
8.15 Zhejiang Medicine
8.16 Biocon
8.17 Johnson Matthey
8.18 Hisun Pharmacy
8.19 Cambrex
8.20 Shandong Xinhua Pharmaceutical
8.21 Lonza group
8.22 Huahai Pharmaceutical
8.23 Haerbin Pharmaceutical Group
8.24 Cipla
8.25 Tian Yao
8.26 Lupin
8.27 North East Pharmaceutical
8.28 Albemarle
8.29 Shandong Lukang Pharmaceutical
8.30 Jiangsu Hengrui Medicine
8.31 Bachem

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Active Pharmaceutical Ingredient Industry Dynamics & Regulations List
Table Global Active Pharmaceutical Ingredient Sales Revenue, Cost and Margin, 2015-2018E
Table Global Active Pharmaceutical Ingredient Market Status by Type 2015-2018E, in USD Million
Table Global Active Pharmaceutical Ingredient Market Status by Application 2015-2018E, in USD Million
Table Global Active Pharmaceutical Ingredient Market Status by Application 2015-2018E, in Volume
Table Global Active Pharmaceutical Ingredient Market by Region 2015-2018E, in USD Million
Table Global Active Pharmaceutical Ingredient Market Share by Region in 2018, in USD Million
Table Global Active Pharmaceutical Ingredient Market by Region 2015-2018E, in Volume
Table Global Active Pharmaceutical Ingredient Market Share by Region in 2018, in Volume
Table Synthetic API Production Value by Region 2015-2018E, in USD Million
Table Synthetic API Production Volume by Region 2015-2018E, in Volume
Table Biotech API Production Value by Region 2015-2018E, in USD Million
Table Biotech API Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Non-steroidal Anti-inflammatory Drugs (NSAIDs) Production Value by Region 2015-2018E, in USD Million
Table Non-steroidal Anti-inflammatory Drugs (NSAIDs) Production Volume by Region 2015-2018E, in Volume
Table Oncology Drugs Production Value by Region 2015-2018E, in USD Million
Table Oncology Drugs Production Volume by Region 2015-2018E, in Volume
Table Anti-diabetic Drugs Production Value by Region 2015-2018E, in USD Million
Table Anti-diabetic Drugs Production Volume by Region 2015-2018E, in Volume
Table Cardiovascular Drugs Production Value by Region 2015-2018E, in USD Million
Table Cardiovascular Drugs Production Volume by Region 2015-2018E, in Volume
Table Central Nervous System Drugs (CNS Drugs) Production Value by Region 2015-2018E, in USD Million
Table Central Nervous System Drugs (CNS Drugs) Production Volume by Region 2015-2018E, in Volume
Table Musculoskeletal Drugs Production Value by Region 2015-2018E, in USD Million
Table Musculoskeletal Drugs Production Volume by Region 2015-2018E, in Volume
Table Other Drugs Production Value by Region 2015-2018E, in USD Million
Table Other Drugs Production Volume by Region 2015-2018E, in Volume
Table Synthetic API Market Size by Region 2015-2018E, in USD Million
Table Synthetic API Market Size by Region 2015-2018E, in Volume
Table Biotech API Market Size by Region 2015-2018E, in USD Million
Table Biotech API Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Size by Region 2015-2018E, in USD Million
Table Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Size by Region 2015-2018E, in Volume
Table Oncology Drugs Market Size by Region 2015-2018E, in USD Million
Table Oncology Drugs Market Size by Region 2015-2018E, in Volume
Table Anti-diabetic Drugs Market Size by Region 2015-2018E, in USD Million
Table Anti-diabetic Drugs Market Size by Region 2015-2018E, in Volume
Table Cardiovascular Drugs Market Size by Region 2015-2018E, in USD Million
Table Cardiovascular Drugs Market Size by Region 2015-2018E, in Volume
Table Central Nervous System Drugs (CNS Drugs) Market Size by Region 2015-2018E, in USD Million
Table Central Nervous System Drugs (CNS Drugs) Market Size by Region 2015-2018E, in Volume
Table Musculoskeletal Drugs Market Size by Region 2015-2018E, in USD Million
Table Musculoskeletal Drugs Market Size by Region 2015-2018E, in Volume
Table Other Drugs Market Size by Region 2015-2018E, in USD Million
Table Other Drugs Market Size by Region 2015-2018E, in Volume
Table GlobalActive Pharmaceutical Ingredient Forecast by Type 2019F-2025F, in USD Million
Table Active Pharmaceutical Ingredient Forecast by Type 2019F-2025F, in Volume
Table Active Pharmaceutical Ingredient Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Active Pharmaceutical Ingredient Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Active Pharmaceutical Ingredient Market Forecast by Region 2019F-2025F, in USD Million
Table Active Pharmaceutical Ingredient Market Forecast by Region 2019F-2025F, in Volume
Table Teva Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Teva
Table Novartis Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Novartis
Table Pfizer Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Pfizer
Table Johnson & Johnson Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Johnson & Johnson
Table Mylan Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Mylan
Table North China Pharmaceutical Group Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of North China Pharmaceutical Group
Table Dr. Reddy's Laboratories Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Dr. Reddy's Laboratories
Table Roche Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Roche
Table Aurobindo pharma Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Aurobindo pharma
Table Sun Pharmaceutical Industries Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Sun Pharmaceutical Industries
Table Boehringer Ingelheim GmbH Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Boehringer Ingelheim GmbH
Table Bayer Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Bayer
Table BASF Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of BASF
Table DSM Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of DSM
Table Zhejiang Medicine Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Zhejiang Medicine
Table Biocon Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Biocon
Table Johnson Matthey Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Johnson Matthey
Table Hisun Pharmacy Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Hisun Pharmacy
Table Cambrex Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Cambrex
Table Shandong Xinhua Pharmaceutical Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Shandong Xinhua Pharmaceutical
Table Lonza group Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Lonza group
Table Huahai Pharmaceutical Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Huahai Pharmaceutical
Table Haerbin Pharmaceutical Group Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Haerbin Pharmaceutical Group
Table Cipla Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Cipla
Table Tian Yao Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Tian Yao
Table Lupin Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Lupin
Table North East Pharmaceutical Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of North East Pharmaceutical
Table Albemarle Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Albemarle
Table Shandong Lukang Pharmaceutical Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Shandong Lukang Pharmaceutical
Table Jiangsu Hengrui Medicine Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Jiangsu Hengrui Medicine
Table Bachem Information
Table Active Pharmaceutical Ingredient Sales, Cost, Margin of Bachem
Table Global Active Pharmaceutical Ingredient Sales Revenue by Company 2015-2017, in USD Million
Table Global Active Pharmaceutical Ingredient Sales Volume by Company 2015-2017, in Volume
Table Global Active Pharmaceutical Ingredient Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Active Pharmaceutical Ingredient Picture
Figure Active Pharmaceutical Ingredient Industry Chain Diagram
Figure Global Active Pharmaceutical Ingredient Sales Revenue 2015-2018E, in USD Million
Figure Global Active Pharmaceutical Ingredient Sales Volume 2015-2018E, in Volume
Figure Global Active Pharmaceutical Ingredient Market Status by Type 2015-2018E, in Volume
Figure North America Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in USD Million
Figure North America Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in Volume
Figure Europe Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in USD Million
Figure Europe Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in Volume
Figure South America Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in USD Million
Figure South America Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in Volume
Figure Middle East Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in Volume
Figure Africa Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in USD Million
Figure Africa Active Pharmaceutical Ingredient Market Size and Growth 2015-2018E, in Volume
Figure Global Active Pharmaceutical Ingredient Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Active Pharmaceutical Ingredient Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Active Pharmaceutical Ingredient Sales Price Forecast 2019F-2025F
Figure Global Active Pharmaceutical Ingredient Gross Margin Forecast 2019F-2025F
Figure Global Active Pharmaceutical Ingredient Sales Revenue by Company in 2018, in USD Million
Figure Global Active Pharmaceutical Ingredient Price by Company in 2018
Figure Global Active Pharmaceutical Ingredient Gross Margin by Company in 2018